Cost-Effectiveness Analysis of Nimodipine Treatment after Aneurysmal Subarachnoid Hemorrhage and Surgery
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 45 (4) , 780-785
- https://doi.org/10.1097/00006123-199910000-00009
Abstract
OBJECTIVE. To assess the cost-effectiveness ratio of nimodipine administration after aneurysmal subarachnoid hemorrhage (SAH) and surgery.METHODS. One hKeywords
This publication has 23 references indexed in Scilit:
- The cost effectiveness of lipid lowering in Swedish primary health careJournal of Internal Medicine, 1996
- Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysisJournal of Neurosurgery, 1996
- Intracranial Aneurysm Surgery in the 8th and 9th Decades of LifeNeurosurgery, 1995
- Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysisJournal of Neurosurgery, 1995
- One-year outcome in early aneurysm surgery: a 14 years experienceActa Neurochirurgica, 1993
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Cost-effectiveness of HMG-CoA Reductase Inhibition for Primary and Secondary Prevention of Coronary Heart DiseasePublished by American Medical Association (AMA) ,1991
- Long-term effects of nimodipine on cerebral infarcts and outcome after aneurysmal subarachnoid hemorrhage and surgeryJournal of Neurosurgery, 1991
- Steps towards cost-benefit analysis of regional neurosurgical care.BMJ, 1990
- Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgeryJournal of Neurosurgery, 1988